The world of stem cell therapy has been held hostage for too long, buried under bureaucracy, patents, and pharma lobbying. StemDAO is here to change that. We are on a mission to accelerate the development of cutting-edge stem cell therapies, free from the artificial constraints of outdated regulatory systems. By leveraging desci and global collaboration through token governance, we’re reclaiming stem cell medicine for the people. Join us in breaking down barriers, funding real innovation, and ensuring that life-altering therapies reach those who need them now, not decades from now.
Number of stem cell clinics (US).
Global medical tourism volume in 2023.
Global unregulated stem cell market.
Regenerative medicine is exploding, but stuck in red tape. We're building the protocol stack to get clinical-grade data and bring stem cell access to the people.
Stem cells, secretomes, and extracellular vesicles (EVs) are powerful tools for reversing tissue damage and age-related decline. Among these, stem cell-derived EVs, which are nano-sized carriers of proteins, RNAs, and lipids, offer a potent, scalable...
We develop polarized MSC-derived EVs to target cognitive decline, skin and systemic aging, and soft tissue injuries. Our preclinical data show enhanced neurogenesis and cognitive function via intranasal delivery, and reduced senescence and inflammation in skin fibroblasts. Exosomes also show promise for lifespan extension.
We’re building a decentralized access layer for stem cell therapies. Our platform connects approved clinics worldwide with patients holding treatment vouchers via tokenized access. It includes patient onboarding, biomarker tracking, and post-treatment reporting.
A regulatory innovation to safely conduct trials outside legacy systems. Our dIRB framework enables community-governed approval of ethical, fast-track regenerative medicine protocols, backed by advisors, clinicians, and Web3 infrastructure.
Value Capture — Building the Stack for Sovereign Biotech...
Elsevier
MDPI
Cell.com